Preparing for a potential A(H7N9) pandemic: Lessons from the deployment of A(H1N1) pandemic vaccines

Expert Review of Vaccines

Volumn 12, Issue 8, 2013, Pages 825-828

  Nguyen Van Tam, Jonathan S ^a   Sellwood, Chloe ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

A(H1N1); A(H7N9); influenza; pandemic; pandemic influenza; preparedness; response; swine flu; vaccine

Indexed keywords

AVIAN INFLUENZA VACCINE; INFLUENZA VACCINE; SWINE INFLUENZA VACCINE;

AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHINA; DISEASE SEVERITY; DRUG MANUFACTURE; DRUG SAFETY; EDITORIAL; GUILLAIN BARRE SYNDROME; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H2N2); INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA A (H7N9); INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A N7N9; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; SWINE INFLUENZA; SWINE INFLUENZA VIRUS; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANIMALS; BIRDS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; PATIENT ACCEPTANCE OF HEALTH CARE; TECHNOLOGY, PHARMACEUTICAL; ZOONOSES;

EID: 84887806631     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2013.814832     Document Type: Editorial

References (19)

1. Gao R, Cao B, Hu Y et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368(20), 1888-1897 (2013
2. Koopmans M, de Jong MD. Avian influenza A H7N9 in Zhejiang, China. Lancet 381(9881), 1882-1883 (2013
3. Chang SY, Lin PH, Tsai JC, Hung CC, Chang SC. The first case of H7N9 influenza in Taiwan. Lancet 381(9878), 1621 (2013
4. Li Q, Zhou L, Zhou M et al. Preliminary report: Epidemiology of the avian influenza A (H7N9) outbreak in China. N. Engl. J. Med. doi:10.1056/ NEJMoa1304617 (2013) (Epub ahead of print
5. Zhang W, Wang L, Hu W et al. Epidemiologic characteristics of cases for influenza A(H7N9) virus infections in china. Clin. Infect. Dis. doi:10.1093/cid/cit277 (2013) (Epub ahead of print
6. Skowronski DM, Janjua NZ, Kwindt TL, De Serres G. Virus-host interactions and the unusual age and sex distribution of human cases of influenza A(H7N9) in China, April 2013. Euro Surveill. 18(17), 20465 (2013
7. Chen Y, Liang W, Yang S et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome. Lancet 381(9881), 1916-1925 (2013
8. Lee SS, Wong NS, Leung CC. Exposure to avian influenza H7N9 in farms and wet markets. Lancet 381(9880), 1815 (2013
9. Uyeki TM, Cox NJ. Global concerns regarding novel influenza A (H7N9) virus infections. N. Engl. J. Med. 368(20), 1862-1864 (2013
10. Henderson DA, Courtney B, Inglesby TV, Toner E, Nuzzo JB. Public health and medical responses to the 1957-58 influenza pandemic. Biosecur. Bioterror. 7(3), 265-73 (2009
11. Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerging Infect. Dis. 12(1), 29-33 (2006
12. Carrasco P, Leroux-Roels G. Pandemic Vaccines. In: Pandemic Influenza (2nd E.d.
13. Van-Tam J, Sellwood C (Eds). CABI, Oxfordshire, UK 139-151 (2012
14. Jennings LC, Monto AS, Chan PK, Szucs TD, Nicholson KG. Stockpiling prepandemic influenza vaccines: A new cornerstone of pandemic preparedness plans. Lancet Infect. Dis. 8(10), 650-658 (2008
15. Principi N, Esposito S. Adjuvanted influenza vaccines. Hum. Vaccin. Immunother. 8(1), 59-66 (2012
16. Hessel L; European Vaccine Manufacturers (EVM) Influenza Working Group. Pandemic influenza vaccines: Meeting the supply, distribution and deployment challenges. Influenza Other Respi. Viruses 3(4), 165-170 (2009
17. Plosker GL. A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®]. Drugs 72(11), 1543-1557 (2012
18. Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe. BMJ 343, d3908 (2011
19. Wijnans L, Lecomte C, de Vries C et al. The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 31(8), 1246-1254 (2013